Brief: A1M Pharma Re-Submits Application To Conduct Clinical Trial With Rosgard

Disruptive Pharma AB (publ)

20/09/2018 09:20

Sept 20 (Reuters) - A1M Pharma AB  A1M.ST :
    * A1M PHARMA RE-SUBMITS APPLICATION TO THE SWEDISH MEDICAL PRODUCTS AGENCY TO CONDUCT
CLINICAL
TRIAL WITH ROSGARD™
    * UPON APPROVAL, PHASE I STUDY IS SCHEDULED TO START IN Q4 2018.
    * STUDY WILL BE CONDUCTED TOGETHER WITH CONTRACT RESEARCH CO CTC IN UPPSALA

Source text for Eikon:  ID:nBQN2lmL1Z 
Further company coverage:  A1M.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))